Home

3 Reasons to Sell CGNX and 1 Stock to Buy Instead

CGNX Cover Image

Cognex has gotten torched over the last six months - since December 2024, its stock price has dropped 21.6% to $30.06 per share. This might have investors contemplating their next move.

Is now the time to buy Cognex, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Do We Think Cognex Will Underperform?

Even though the stock has become cheaper, we're cautious about Cognex. Here are three reasons why we avoid CGNX and a stock we'd rather own.

1. Revenue Growth Flatlining

Long-term growth is the most important, but within business services, a stretched historical view may miss new innovations or demand cycles. Cognex’s recent performance shows its demand has slowed as its revenue was flat over the last two years. Cognex Year-On-Year Revenue Growth

2. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Cognex’s margin dropped by 12.2 percentage points over the last five years. It may have ticked higher more recently, but shareholders are likely hoping for its margin to at least revert to its historical level. If the longer-term trend returns, it could signal it is in the middle of an investment cycle. Cognex’s free cash flow margin for the trailing 12 months was 17.7%.

Cognex Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, Cognex’s ROIC has decreased significantly over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Cognex Trailing 12-Month Return On Invested Capital

Final Judgment

Cognex falls short of our quality standards. After the recent drawdown, the stock trades at 33.5× forward P/E (or $30.06 per share). This valuation tells us it’s a bit of a market darling with a lot of good news priced in - we think there are better investment opportunities out there. We’d recommend looking at our favorite semiconductor picks and shovels play.

Stocks We Would Buy Instead of Cognex

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.